Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)

China · Delayed Price · Currency is CNY

17.21

-0.44 (-2.49%)

Mar 30, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Technical Services					19.07M	14.03M
Technical Services Growth					35.90%	-
Cardiovascular					1.37B	554.49M
Cardiovascular Growth					147.44%	-
Anti-Infective					1.57B	1.30B
Anti-Infective Growth					20.71%	-
Digestive System					542.40M	459.14M
Digestive System Growth					18.13%	-
Hypoglycemic					260.27M	109.45M
Hypoglycemic Growth					137.81%	-
Active Pharmaceutical Ingredient (API)					95.07M	65.73M
Active Pharmaceutical Ingredient (API) Growth					44.63%	-
Other					44.31M	31.18M
Other Growth					42.10%	-
Total					3.90B	2.53B
Total Growth					54.02%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Overseas					29.92M	9.57M
Overseas Growth					212.77%	-
East China					1.02B	647.56M
East China Growth					58.07%	-
North China					739.06M	476.05M
North China Growth					55.25%	-
Central					747.82M	459.85M
Central Growth					62.62%	-
Southwest Region					516.26M	379.21M
Southwest Region Growth					36.14%	-
Northeast China Region					316.90M	219.40M
Northeast China Region Growth					44.44%	-
Northwestern Region					313.61M	189.64M
Northwestern Region Growth					65.37%	-
Southern China					213.47M	151.35M
Southern China Growth					41.05%	-
Total					3.90B	2.53B
Total Growth					54.02%	-

Source: S&P Global Market Intelligence.